Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Surgical Treatments of Hepatobiliary Cancers
Ganesh Gunasekaran, Yuki Bekki, Vennis Lourdusamy, et al.
Hepatology (2020) Vol. 73, Iss. S1, pp. 128-136
Closed Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
Farah Abdelhameed, Chris Kite, Lukasz Lagojda, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 3, pp. 510-531
Open Access | Times Cited: 38
Photocrosslinked methacrylated natural macromolecular hydrogels for tissue engineering: A review
Xiaoli Yang, Xiaojing Li, Zhaoping Wu, et al.
International Journal of Biological Macromolecules (2023) Vol. 246, pp. 125570-125570
Closed Access | Times Cited: 31
MicroRNA biosensors for the detection of liver cancer
Mehdi Fattahi, Fereshteh Rahdan, Donya Shaterabadi, et al.
Clinica Chimica Acta (2024) Vol. 554, pp. 117796-117796
Closed Access | Times Cited: 15
Doxorubicin prodrug for γ-glutamyl transpeptidase imaging and on-demand cancer therapy
Yanhua Li, Jiexiang Zhao, Kun Tang, et al.
Biosensors and Bioelectronics (2025) Vol. 272, pp. 117127-117127
Closed Access | Times Cited: 1
A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma
Tan Zhang, Sina Zhang, Jin Chen, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 48
Codelivery of resveratrol melatonin utilizing pH responsive sericin based nanocarriers inhibits the proliferation of breast cancer cell line at the different pH
Faranak Aghaz, Zahra Asadi, Soraya Sajadimajd, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Magnetic Metal–Organic Framework-Based Nanoplatform with Platelet Membrane Coating as a Synergistic Programmed Cell Death Protein 1 Inhibitor against Hepatocellular Carcinoma
Hong Guo, Yuping Liu, Xia Li, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23829-23849
Open Access | Times Cited: 17
Nanoparticle-mediated immunogenic cell death for cancer immunotherapy
Haolong Qi, Yuan Li, Yingjie Geng, et al.
International Journal of Pharmaceutics (2024) Vol. 656, pp. 124045-124045
Closed Access | Times Cited: 7
Roles of MET in human cancer
Xin Yang, Hai-Yang Liao, Haihong Zhang
Clinica Chimica Acta (2021) Vol. 525, pp. 69-83
Closed Access | Times Cited: 37
Progress in Radiotherapy for Cholangiocarcinoma
Ningyu Wang, Ai Huang, Bo‐Hua Kuang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Biomarkers for response to immunotherapy in hepatobiliary malignancies
Zhifei Lin, Lun‐Xiu Qin, Jinhong Chen
Hepatobiliary & pancreatic diseases international (2022) Vol. 21, Iss. 5, pp. 413-419
Closed Access | Times Cited: 23
MVI-TR: A Transformer-Based Deep Learning Model with Contrast-Enhanced CT for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma
Linping Cao, Qing Wang, Jiawei Hong, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1538-1538
Open Access | Times Cited: 16
Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation
Xueyan Cao, Yang Yang, Wei Zhou, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside
Kai Zhao, Xiangyu Li, Yunxiang Feng, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Homologous-magnetic dual-targeted metal-organic framework to improve the Anti-hepatocellular carcinoma efficacy of PD-1 inhibitor
Hong Guo, Xia Li, Dengxuan Mao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Improved anti-hepatocellular carcinoma effect by enhanced Co-delivery of Tim-3 siRNA and sorafenib via multiple pH triggered drug-eluting nanoparticles
Chenghua Song, Jia Zhang, Ruichao Wen, et al.
Materials Today Bio (2022) Vol. 16, pp. 100350-100350
Open Access | Times Cited: 19
Contrast-enhanced ultrasound-based AI model for multi-classification of focal liver lesions
Wenzhen Ding, Yaqing Meng, Jun Ma, et al.
Journal of Hepatology (2025)
Closed Access
Efficacy and factors related to prognosis of combination chemotherapy with different radiotherapy methods in patients with unresectable hepatocellular carcinoma
Lian-Qiang Han
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma
Shan Gao, Tianxiang Chen, Lijie Li, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 32
miR‐885‐5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma
Lixin Sun, Wei Sun, Song Hai-bin, et al.
Molecular Carcinogenesis (2020) Vol. 59, Iss. 12, pp. 1371-1381
Closed Access | Times Cited: 31
Multi-functionalized dendrimers for targeted co-delivery of sorafenib and paclitaxel in liver cancers
Guanglan Ma, Xiao Du, Jianping Zhu, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 63, pp. 102493-102493
Closed Access | Times Cited: 27
The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma
Jie Zhu, Peiqi Fang, Chong Wang, et al.
Cancer Medicine (2021) Vol. 10, Iss. 22, pp. 7977-7987
Open Access | Times Cited: 26
From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
Raphael Mohr, Burcin Özdirik, Joeri Lambrecht, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1492-1492
Open Access | Times Cited: 25
Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property
Xiaowei Wang, Yaxuan Gu, Qi Li, et al.
Colloids and Surfaces B Biointerfaces (2021) Vol. 209, pp. 112164-112164
Closed Access | Times Cited: 25
A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer
Mingzhen Zhou, Yuncheng Jin, Sihui Zhu, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top